Supercharge Your Innovation With Domain-Expert AI Agents!

Medicine composition for treating phlegm-heat obstructive pulmonary type asthma

A technology for phlegm-heat blocking lung and composition, which is applied in the field of pharmaceutical compositions for treating phlegm-heat blocking lung type asthma, can solve problems such as side effects, easy recurrence, strong dependence, etc., and achieves no toxic side effects, less recurrence, and curative effect. exact effect

Inactive Publication Date: 2016-06-15
程丽莉
View PDF0 Cites 1 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

[0005] At present, there are many drugs for the treatment of asthma, but they are highly dependent, have side effects, and are prone to relapse

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0029] A pharmaceutical composition for treating phlegm-heat obstructing lung type asthma, which is composed of the following traditional Chinese medicine raw materials in the following weight proportions: 5 parts of Mopancao, 5 parts of Rabbit's Ear Grass, 10 parts of Chrysanthemum chrysanthemum, 5 parts of Xuesanshu, and Scissors 5 parts, 8 parts of lotus root, 8 parts of banyan leaf, 10 parts of small fruit row grass, 5 parts of water hair flower, 5 parts of large fruit Morinda officinalis, 10 parts of lobelia, 5 parts of Erlang sword, 5 parts of palm leaf reed, 10 parts of Chinese kale, 13 parts of lotus, and 13 parts of Artemisia chinensis.

Embodiment 2

[0031] A medicinal composition for treating phlegm-heat obstructing lung type asthma, which is composed of the following traditional Chinese medicine raw materials in the following weight proportions: 3 parts of Mopancao, 7 parts of Rabbit's Ear Grass, 13 parts of Hazel Chrysanthemum, 3 parts of Xuesanshu, and Scissors 6 parts, 9 parts of lotus root, 6 parts of banyan leaf, 13 parts of small fruit row grass, 3 parts of water hair flower, 6 parts of large fruit Morinda officinalis, 15 parts of lobelia, 3 parts of Erlang sword, 4 parts of palm leaf reed, 5 parts of kale, 15 parts of lotus, and 10 parts of Artemisia chinensis.

Embodiment 3

[0033] A pharmaceutical composition for treating phlegm-heat obstructing lung type asthma, which is composed of the following traditional Chinese medicine raw materials in the following weight proportions: 4 parts of Mopancao, 5 parts of Rabbit's Ear Grass, 8 parts of Hazel Chrysanthemum, 6 parts of Xuesanshu, and Scissors 5 parts, 10 parts of lotus root, 5 parts of banyan tree, 15 parts of small fruit row grass, 6 parts of water hair flower, 8 parts of large fruit Morinda officinalis, 8 parts of lobelia, 6 parts of Erlang sword, 3 parts of palm leaf reed, There are 13 parts of kale, 12 parts of lotus, and 15 parts of Artemisia chinensis.

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

No PUM Login to View More

Abstract

The invention relates to a medicine composition for treating phlegm-heat obstructive pulmonary type asthma. The medicine composition is prepared from the following traditional Chinese medicine raw materials in parts by weight: 3 to 5 parts of abutilon indicum, 5 to 7 parts of leontopodium longifolium ling, 8 to 15 parts of herba asteris ageratoidis, 3 to 7 parts of radix stephaniae dielsianae, 5 to 7 parts of clinopodium herb, 8 to 10 parts of lotus corniculatus, 5 to 8 parts of ficus hispida, 7 to 15 parts of lysimachia microcarpa, 3 to 7 parts of scirpus triangulatus roxb, 5 to 8 parts of morinda cochinchinensis DC, 8 to 15 parts of lobelia sessilifolia lamb, 3 to 7 parts of gentiana rubicunda, 3 to 5 parts of thysanolaena maxima, 5 to 15 parts of cabbage mustard, 10 to 15 parts of radix aster auriculatus franch and 10 to 15 parts of herb of blin conyza. The medicine composition provided by the invention has the effects of dispelling wind and clearing away heat, opening the lung and stopping cough, and relieving asthma and lowering the adverse flow of qi, has the accurate curative effect of treating phlegm-heat obstructive pulmonary type asthma and has high efficiency; phlegm-heat obstructive pulmonary type asthma is not easy to reoccur and the medicine composition has no toxic or side effect.

Description

technical field [0001] The invention belongs to the field of traditional Chinese medicines and relates to a pharmaceutical composition for treating asthma of phlegm-heat blocking lung type. Background technique [0002] Asthma is a chronic airway inflammatory disease involving a variety of cells and cellular components. This chronic inflammation is associated with airway hyperresponsiveness, usually with extensive and variable reversible airflow limitation, leading to recurrent wheezing, Symptoms such as shortness of breath, chest tightness, and (or) cough usually occur and intensify at night and (or) early morning, and most patients can relieve themselves or be relieved by treatment. [0003] Traditional Chinese medicine believes that the etiology of asthma has both exogenous pathogenic factors and internal injuries. Exogenous pathogenic factors: wind-cold, wind-heat attack, or allergies affected by smoke, paint, pollen, etc., can cause loss of lung qi and block airways; i...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
Patent Type & Authority Applications(China)
IPC IPC(8): A61K36/899A61P11/06
CPCA61K36/185A61K36/28A61K36/31A61K36/34A61K36/48A61K36/53A61K36/59A61K36/60A61K36/746A61K36/89A61K36/899A61K2300/00
Inventor 程丽莉
Owner 程丽莉
Features
  • R&D
  • Intellectual Property
  • Life Sciences
  • Materials
  • Tech Scout
Why Patsnap Eureka
  • Unparalleled Data Quality
  • Higher Quality Content
  • 60% Fewer Hallucinations
Social media
Patsnap Eureka Blog
Learn More

Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.

© 2025 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com